Why do we like the bitter taste of coffee? Bitterness evolved as a natural warning system to protect the body from harmful substances. By evolutionary logic, we should want to spit it out.
But, it turns out, the more sensitive people are to the bitter taste of caffeine, the more coffee they drink, reports a new study published in Scientific Reports. The sensitivity is caused by a genetic variant.
"You'd expect that people who are particularly sensitive to the bitter taste of caffeine would drink less coffee," said the senior author. "The opposite results of our study suggest coffee consumers acquire a taste or an ability to detect caffeine due to the learned positive reinforcement (i.e. stimulation) elicited by caffeine."
In other words, people who have a heightened ability to taste coffee's bitterness -- and particularly the distinct bitter flavor of caffeine -- learn to associate "good things with it," the senior author said.
In this study population, people who were more sensitive to caffeine and were drinking a lot of coffee consumed low amounts of tea. But that could just be because they were too busy drinking coffee, the senior author noted.
The study also found people sensitive to the bitter flavors of quinine and of PROP, a synthetic taste related to the compounds in cruciferous vegetables, avoided coffee. For alcohol, a higher sensitivity to the bitterness of PROP resulted in lower alcohol consumption, particularly of red wine.
"The findings suggest our perception of bitter tastes, informed by our genetics, contributes to the preference for coffee, tea and alcohol," the senior author said.
For the study, scientists applied Mendelian randomization, a technique commonly used in disease epidemiology, to test the causal relationship between bitter taste and beverage consumption in more than 400,000 men and women in the United Kingdom. The genetic variants linked to caffeine, quinine and PROP perception were previously identified through genome-wide analysis of solution taste-ratings collected from Australian twins. These genetic variants were then tested for associations with self-reported consumption of coffee, tea and alcohol in the current study.
"Taste has been studied for a long time, but we don't know the full mechanics of it," the senior author said. "Taste is one of the senses. We want to understand it from a biological standpoint."
https://news.northwestern.edu/stories/2018/november/bitter-coffee/
https://www.nature.com/articles/s41598-018-34713-z
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Funderstanding-the-role&filter=22&keep_no_swfupload=1
Latest News
Zone 2 hepatocytes help in maintenance and regeneration of liver
Nanobody-mediated control of gene expression and epigenetic memory
Re-engineering Botox for Multiple Functions
New signaling pathway in neurons
Mother's diet boosts immune systems of premature infants
Other Top Stories
First cell culture of live adult human neurons shows potential of brain cell types
Important bio-chemical produced on a large scale by E. coli
Using E. coli to detect hormone disruptors in the environment
Remote-controlled bacteria made to swim
Optogenetic tool that inhibits neural activity
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Nanobody-mediated control of gene expression and epigenetic memory
Interaction of 7SK with the Smn complex modulates snRNP production
Maternal aryl hydrocarbon receptor activation protects newborns against necrotizing enterocolitis
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum
Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemica…
Presentations
Botulinum toxin
Bioplar Disorder
G-Protein-Coupled Receptors
Mood Disorders
Mitochondrial DNA
Posters
ASCO-2020-CENTRAL NERVOUS SYSTEM TUMORS
ASCO-2020-DEVELOPMENTAL THERAPEUTICS–IMMUNOTHERAPY
ASCO-2020-DEVELOPMENTAL THERAPEUTICS–MOLECULARLY TARGETED AGENTS AND TUMOR BIOLOGY
ASCO-2020-CANCER PREVENTION, RISK REDUCTION, AND GENETICS
ASCO-2020-BREAST CANCER–METASTATIC